Thank you, Rick, and good afternoon, everyone. Thanks for joining us today. Total revenue for the fourth quarter of 2024 was $8.1 million compared with revenue of $9.8 million in the same quarter last year, a decrease of 17.2%. For the full year, total revenue was $34.6 million compared with $37.9 million in 2023. Our total revenue is made up of two components: franchise royalties, which is our primary source of revenue and service revenue, which is generated from certain service and interest charge to our franchisee as well as other miscellaneous revenue. Franchise royalties for the fourth quarter were $7.6 million compared to $8.9 million for the same quarter last year. For the full year, franchise royalties were $32.7 million compared with $35.8 million in 2023. Underlying franchise royalties are system-wide sales, which are not part of our revenue, but are helpful contextual performance indicator. System-wide sales reflect sales at all offices, including those classified as discontinued. System-wide sales for the fourth quarter were $134.8 million compared to $143.5 million in the fourth quarter of 2023. Full year system-wide sales were $563.6 million compared with $605.1 million in 2023. The decrease in our revenue on an annual basis is roughly consistent with the decrease in underlying system-wide sales and as Rick pointed out, was driven by a softening of the overall staffing market throughout 2024. The impact of this was most acutely felt in our permanent placement and executive search business primarily MRI network, which declined 18.6% when compared with 2023 results for the segment. Service revenue was $439,000 for the fourth quarter compared to $871,000 in the year ago period. Service revenue for the fourth quarter of 2023 included pass-through revenue of $515,000 related to the MRI network advertising fund, which was for the full year of 2023, while fourth quarter 2024 service revenue only included advertising fund revenue for the quarter. Full year 2024 service revenue was $1.9 million compared to $2.1 million in the prior year. Service revenue is composed of interest charge for our franchisee on overdue accounts receivable, service fees, other miscellaneous revenue and MRI Networks advertising fund revenue and can fluctuate from quarter-to-quarter based on several factors, including growth in system-wide sales, changes in accounts receivable, insurance renewals and similar dynamics. Selling, general and administrative expenses, SG&A for the fourth quarter were $5.1 million compared to $6.6 million in the prior year period, a decrease of 22.7%. Additionally, SG&A expenses for the fourth quarter of 2023 included $515,000 of expense related to the MRI network advertising fund, which is for the full year of 2023, of fourth quarter 2024 SG&A only included expenses related to the advertising fund for the quarter. SG&A expenses for the full year decreased 12.4% to $21.4 million compared with $24.4 million in 2023. As Rick stated, the reduction in our SG&A expenses was primarily driven by reduced workers' compensation expense, which decreased approximately 46% to $2 million in 2024 compared with $3.7 million in 2023. Workers' compensation expense will generally fluctuate based on a mix of classifications, the level of payroll, recent plan resolutions and cumulative experience. While we cannot accurately predict the effects of workers' compensation in future periods, we believe we'll continue to see it go down further in 2025. Net income after tax was $2.2 million in the fourth quarter of 2024 or $0.16 per diluted share compared to a net income of $15,000 or zero earnings per share in the fourth quarter of 2023. Net income for the full year was $3.7 million or $0.26 per diluted share compared with net income of $6.1 million or $0.45 per diluted share in 2023. As we stated last year, full year net income included a -- excuse me, last quarter, full year net income included a non-cash impairment charge of $6 million in the third quarter related to the MRI network assets that we acquired in December 2022. This charge had a considerable impact on our profitability, both in the quarter and year-to-date period. And as such, we determine that providing an adjusted net income figure would be a helpful metric to better showcase growth and progress that we've achieved. With that said, adjusted net income for the fourth quarter of 2024, which excludes the non-cash impairment charge of $6 million, amortization of acquired intangibles and other non-recurring onetime expenses was $2.6 million or $0.19 per diluted share and compared to adjusted net income of $2.5 million or $0.18 per diluted share in the fourth quarter of 2023. Adjusted net income for the full year was $9.9 million or $0.71 per diluted share compared to adjusted net income of $9.9 million or $0.72 per diluted share in the prior year period. We have provided a table in the press release issued earlier this afternoon with a detailed reconciliation of adjusted net income to net income. Adjusted EBITDA in the fourth quarter of 2024 was $3.8 million compared to $4.3 million in the prior year period. Adjusted EBITDA margin for the quarter was 47% compared to 44% in the fourth quarter of 2023. For the full year, adjusted EBITDA was $16.1 million compared to $16.5 million in the prior year. Adjusted EBITDA margin in 2024 was 47% and compared to 44% in 2023. We believe adjusted EBITDA is a relevant metric for us due to size of non-cash operating expenses running through our P&L. A detailed reconciliation of adjusted EBITDA to net income is provided in our 10-K, which we filed this afternoon as well as our press release. Moving now to the balance sheet. Our current assets at December 31, 2024, were $49.2 million compared to $51.5 million at December 31, 2023. Current assets as of December 31, 2024, included $2.2 million in cash and $42.3 million of net accounts receivable while current assets at December 31, 2023, included $1.3 million of cash and $44.4 million of net accounts receivable. Current assets exceeded current liabilities by $25.1 million at December 31, 2024, versus year-end 2023 when working capital was $15.7 million. Current liabilities were 49% of current assets at December 31, 2024, versus 69% of current assets at December 31, 2023. At December 31, 2024, we had $6.8 million drawn on our credit facility and another $33.4 million in availability, assuming continued covenant compliance. Importantly, our credit facility was not impacted by the non-cash impairment charge that we recognized in the quarter. We believe our credit facility provides us with flexibility and room for short-term working capital needs as well as the capacity to capitalize on potential acquisitions. We have paid a regular quarterly dividend since the third quarter of 2020. Most recently, we paid a $0.06 per common share dividend from March 17, 2025, and to shareholders of record as of March 3. We expect to continue to pay a dividend each quarter subject to the board's discretion. With that, I will turn the call back over to Rick for some closing comments.